1. 1. Koyanagi K, Kubota T, Kobayashi D, Kihara T, Yoshida T, Miisho T, Saito Y, Uchigoshi H, Takaki J, Seo T, Shimazoe T. Setsuyaku BAG Campaign: Investigation of leftover s retained by outpatients and Promotion of proper reuse leftover s to reduce medical expenses. Yakugaku Zasshi. 2013; 133:1215-1221. (in Japnese)
2. 2. Nakamura K, Urano K, Tanaka M, Nishiguchi K, Sakai Y, Katano T, Nabekura T, Yamamura K, Kunimasa J. Reduction impact in medical expenses of pharmaceutical inquiries on leftover medicines at a community pharmacy. Jpn J Pharm Health Care Sci. 2014; 40:522-529. (In Japanese)
3. 3. Sasaki T. An inadvertent contraindicated combined use of newly prescribed TS-1 and unused doxifluridine. Gan To Kagaku Ryoho. 2007; 34:653-656. (In Japanese)
4. 4. Medical Economics Division, Health Insurance Bureau. Revised FY2012 Report on Healthcare Compensation (Notification). 2012 March. Notification No.: 0305-1. https://www.mhlw.go.jp/seisakunitsuite/bunya/hukushi_kaigo/seikatsuhogo/tannokyuuin/dl/5-2-3.pdf (accessed August 3, 2018).
5. 5. Medical Economics Division, Health Insurance Bureau. Revised FY2014 Report on Healthcare Compensation (Notification). 2014 March. Notification No.: 0305-1. http://www.mext.go.jp/a_menu/shotou/tokubetu/material/__icsFiles/afieldfile/2014/09/09/1351772_1.pdf (accessed August 3, 2018).